8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.77%
Revenue growth under 50% of 9843.T's 15.66%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.33%
Gross profit growth under 50% of 9843.T's 12.30%. Michael Burry would be concerned about a severe competitive disadvantage.
7.47%
EBIT growth below 50% of 9843.T's 22.77%. Michael Burry would suspect deeper competitive or cost structure issues.
11.60%
Operating income growth at 75-90% of 9843.T's 13.06%. Bill Ackman would demand a plan to enhance operating leverage.
7.06%
Net income growth under 50% of 9843.T's 32.18%. Michael Burry would suspect the firm is falling well behind a key competitor.
7.10%
EPS growth under 50% of 9843.T's 32.72%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.10%
Diluted EPS growth under 50% of 9843.T's 32.78%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.00%
Slight or no buybacks while 9843.T is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.00%
Slight or no buyback while 9843.T is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-113.60%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-470.38%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
30.78%
10Y revenue/share CAGR above 1.5x 9843.T's 9.04%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
30.78%
5Y revenue/share CAGR above 1.5x 9843.T's 9.04%. David Dodd would look for consistent product or market expansions fueling outperformance.
30.78%
3Y revenue/share CAGR above 1.5x 9843.T's 9.04%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
73.51%
10Y OCF/share CAGR above 1.5x 9843.T's 10.04%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
73.51%
5Y OCF/share CAGR above 1.5x 9843.T's 10.04%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
73.51%
3Y OCF/share CAGR above 1.5x 9843.T's 10.04%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
96.43%
Net income/share CAGR above 1.5x 9843.T's 2.08% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
96.43%
5Y net income/share CAGR above 1.5x 9843.T's 2.08%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
96.43%
3Y net income/share CAGR above 1.5x 9843.T's 2.08%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
48.59%
10Y equity/share CAGR above 1.5x 9843.T's 10.16%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.59%
5Y equity/share CAGR above 1.5x 9843.T's 10.16%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
48.59%
3Y equity/share CAGR above 1.5x 9843.T's 10.16%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.84%
Inventory is declining while 9843.T stands at 24.67%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.83%
Negative asset growth while 9843.T invests at 9.75%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.96%
Positive BV/share change while 9843.T is negative. John Neff sees a clear edge over a competitor losing equity.
-10.36%
We’re deleveraging while 9843.T stands at 62.41%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.